RE-ALIGN
2013
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
In 252 patients with a mechanical aortic or mitral valve, dabigatran led to more thromboembolic events and major bleeding compared with warfarin.
Result
- Absolute difference
- 5 points
The absolute difference is derived from the event rates.
Also reported: Major bleed 4 % vs 2 %. Trial halted for harm.
- Subtopic
- Anticoagulation
- Design
- Phase II, open-label, dose-validation; stopped early
- Relevance
- Important: one of several pillars.
- Cited in
- ACC/AHA 2020 VHD
- Source
- Eikelboom JW, et al. N Engl J Med. 2013;369(13):1206-1214.doi 10.1056/NEJMoa1300615
Discussion & critique
Confirms: NOACs are not interchangeable with VKAs for mechanical valves. Warfarin remains the only validated agent; INR targets depend on valve type & position.